Posted On: 10/14/2014 3:03:13 PM
Post# of 30067
Lol....if I was to "adopt a middle-aged man" my wife would certainly do a double take!
Amarantus is a bargain now, and actually shows resilience in today's trading session. As I said earlier, it only takes 1 or 2 impatient longs to sell their holdings to drop the sp significantly as we see today. But, who knows.
I really don't think the general market movements affect AMBS (DJIA, NYSE etc.), after all, it's a pre-revenue bio play on the OTC. That being said, it's a pre-revenue bio play with admirable science attached and don't think that a major pharma company doesn't take notes on the AMBS pipeline they have accumulated to date. MANF is the big carrot though and it's early in it's development. I would just love to pick GC's brain though or be the fly on the wall...
Sit back and enjoy the ride...hopefully the "self-proclaimed experts" don't sway those that have been accumulating to date and have been holding as long as many have, as frustrating as it has been at times...
Amarantus is a bargain now, and actually shows resilience in today's trading session. As I said earlier, it only takes 1 or 2 impatient longs to sell their holdings to drop the sp significantly as we see today. But, who knows.
I really don't think the general market movements affect AMBS (DJIA, NYSE etc.), after all, it's a pre-revenue bio play on the OTC. That being said, it's a pre-revenue bio play with admirable science attached and don't think that a major pharma company doesn't take notes on the AMBS pipeline they have accumulated to date. MANF is the big carrot though and it's early in it's development. I would just love to pick GC's brain though or be the fly on the wall...
Sit back and enjoy the ride...hopefully the "self-proclaimed experts" don't sway those that have been accumulating to date and have been holding as long as many have, as frustrating as it has been at times...
(0)
(0)
